Mohammad Hout
American University of Beirut Medical Center, Brown University
Papers
2
Total Citations
10
H-Index
2
About
Dr. Mohammad Hout is a urologic oncologist whose research focuses on improving risk stratification and surgical outcomes in prostate cancer. His most cited work, a 2020 study developing a novel nomogram that incorporates the platelet-to-lymphocyte ratio, provides a more accurate, non-invasive tool for predicting lymph node involvement in prostate carcinoma—a critical factor in treatment planning. This contribution has garnered significant attention, with 6 citations, reflecting its clinical utility in personalizing patient care. Dr. Hout also explores the intersection of emerging technologies and surgery, as demonstrated by his case report on performing robot-assisted laparoscopic radical prostatectomy just six months after rectal spacer hydrogel injection. This work, cited 4 times, challenges conventional wisdom about the timing of surgery following SpaceOAR placement, a hydrogel used to protect the rectum during radiation therapy. By demonstrating the feasibility of this approach, Dr. Hout expands surgical options for patients who have undergone prior radiation-sparing procedures. His research bridges the gap between predictive analytics and innovative surgical techniques, marking him as a thoughtful contributor to the evolving landscape of prostate cancer management.
Research Focus
Key Achievements
Top Papers
- 1
- 2